Biobytes
PrivateLast Round
Early Funding
Jun 4, 2026
Total Funding Raised
$1.85M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Biobytes is a health technology company that develops AI-powered platforms for sarcopenia risk assessment, biomarker discovery, and muscle health management.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Drug Discovery, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biobytes Comparables
Compare Biobytes with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Biomdcare Corporation | 82% | |
| IMOON HEALTHCARE Co., Ltd. | 71% | |
| ClariPi Inc. | 68% |
Biobytes Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jun 4, 2026 | ||||
| Seed | Nov 15, 2024 |
Key People
Founding team and executive leadership
Biobytes Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KOTEC | Early Funding |
| Gangwon Creative Economy Innovation Center | Seed |
| CNT Tech | Seed |
| Sopoong Ventures | Seed |
| Newborn Ventures | Early Funding |
| Kingsley Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 4, 2026
$1.4M raised from Newborn Ventures and KOTEC.
- Feb 6, 2026
Grew 300% QoQ, from 3 to 12 employees.
Biobytes Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Biobytes's valuation, stock price, and market status.
Is Biobytes a public or private company?
Biobytes is a private company.
What is the current stock price of Biobytes?
Biobytes is a private company with no public stock price. No recent secondary market data is available.
How much is Biobytes worth (valuation)?
Valuation information for Biobytes is not publicly available.
Can I buy Biobytes stock?
Biobytes shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Biobytes's last funding round?
Biobytes's most recent funding round was Early Funding on June 4, 2026.
Who are the main investors in Biobytes?
Key investors in Biobytes include Kingsley Ventures.
Will Biobytes IPO soon?
No public IPO plans have been announced for Biobytes.
How can I track Biobytes secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Biobytes's secondary market activity and sign up for updates.